AUG 20, 2014 11:45 AM PDT

Ethical, Legal and Social Issues of Direct-to-Consumer Genetic Testing

C.E. CREDITS: CEU
Speakers
  • Senior Researcher, Uppsala University, Centre for Research Ethics & Bioethics
    Biography
      Heidi Carmen Howard is a senior researcher at the Centre for Research Ethics and Bioethics at Uppsala University (Sweden).She received her undergraduate and doctoral degrees in Biology from McGill University (Montréal, Canada). The focus of her PhD was neurogenetics and she continued her genetics training in psychiatric genetics at the Centre for Genomic Regulation in Barcelona (Spain) and at the Douglas Hospital in Montréal (Canada). With an Erasmus Mundus fellowship, she completed the Erasmus Mundus Master of Bioethics programme in 2008. She then spent four years with the support of the European Commission FP7 Marie Curie Career Development Awards (2009-2011; 2011-2013) which allowed her to work on the ethical, legal and social issues (ELSI) related to genetics and genomics as well as biobanking at KULeuven (Belgium) and inserm (France) respectively.Currently, her main areas of research are the ELSI of risk information in genetics and genomics, direct-to-consumer genetic testing, public health genomics, new genomic technologies, participant-centric research initiatives and the translation of genomics from the laboratory to the clinic.Dr. Howard is also an invited scholar at the Centre of Genomics and Policy at McGill University and a member of the Public and Professional Policy Committee of the European Society of Human Genetics.

    Abstract:

    Direct-to-consumer (DTC) genetic testing can be understood as including two related aspects: first, the advertising of genetic tests directly to consumers; and second, the direct access or ordering of genetic tests outside of the traditional healthcare setting and often without the intermediate of a healthcare professional. The types of tests sold by these companies include single gene tests, multiple genes tests and genome-wide-testing also known as personal genome scanning, whereby hundreds of thousands to millions of genetic markers (often single nucleotide polymorphisms) are tested throughout the genome. Although not so common, some companies are also now selling whole genome and whole exome sequencing DTC. Although the majority of the popular media coverage and much of the academic debates have focussed on companies selling genome-wide-testing services (from companies such as 23andMe, and in the past deCODE and Navigenics), there are also many DTC genetic testing companies that do not sell this type of testing. Also contributing to the variation in the DTC genetic testing market is the great deal of variation regarding the purpose of the tests on offer; for example, different tests can provide information regarding ancestry, carrier status, disease risk (presymptomatic, prenatal, susceptibility), nutrigenomics or pharmacogenomics. The advent of this commercial offer of genetic testing, raises some new and not so new ethical, legal and social issues (ELSI). In this presentation, I will describe the phenomena of DTC genetic testing, present what advocates and critiques have to say about this offer, and discuss the ELSI.


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 29, 2018 09:00 AM PDT
    C.E. CREDITS
    JUN 29, 2018 09:00 AM PDT
    DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
    Loading Comments...